Citation Impact
9 by Nobel laureates 24 from Science/Nature 60 standout
Citing Papers
New promises and challenges in the treatment of advanced non-small-cell lung cancer
2024 Standout
A view on drug resistance in cancer
2019 StandoutNature
Works of David Sternberg being referenced
Efficacy and safety of patritumab deruxtecan (HER3-DXd) in advanced/metastatic non-small cell lung cancer (NSCLC) without EGFR-activating mutations.
2022
Phase Ib Study of Buparlisib plus Trastuzumab in Patients with HER2-Positive Advanced or Metastatic Breast Cancer That Has Progressed on Trastuzumab-Based Therapy
2014
Author Peers
| Author | Molecular Biology | Oncology | Hematology | Biomedical Engineering | Biotechnology | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|---|
| David Sternberg | 2040 | 731 | 722 | 1022 | 736 | 107 | 4.3k | |
| D. Ruvalcaba | 8 | 9 | 395 | |||||
| Claudia M. Trujillo‐Vargas | 104 | 53 | 28 | 2 | 30 | 552 | ||
| F. Briones | 5 | 161 | 38 | 636 | ||||
| E. M. Rapoport | 379 | 33 | 6 | 5 | 18 | 32 | 505 | |
| G. Gagnon | 8 | 3 | 18 | 2 | 25 | 460 |
All Works
Login with ORCID to disown or claim papers
Loading papers...